Your browser doesn't support javascript.
loading
Locally secreted BiTEs complement CAR T cells by enhancing killing of antigen heterogeneous solid tumors.
Yin, Yibo; Rodriguez, Jesse L; Li, Nannan; Thokala, Radhika; Nasrallah, MacLean P; Hu, Li; Zhang, Logan; Zhang, Jiasi Vicky; Logun, Meghan T; Kainth, Devneet; Haddad, Leila; Zhao, Yang; Wu, Tong; Johns, Emily X; Long, Yu; Liang, Hongsheng; Qi, Jiping; Zhang, Xiangtong; Binder, Zev A; Lin, Zhiguo; O'Rourke, Donald M.
Affiliation
  • Yin Y; Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, 150001, China; Center for Cellular Immunotherapies, University of Pennsylvania Philadelphia, PA 19104, USA; GBM Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Philadelp
  • Rodriguez JL; Center for Cellular Immunotherapies, University of Pennsylvania Philadelphia, PA 19104, USA; GBM Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Philadelphia, PA 19104, USA; Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Ph
  • Li N; Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, 150001, China; Center for Cellular Immunotherapies, University of Pennsylvania Philadelphia, PA 19104, USA; GBM Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Philadelp
  • Thokala R; Center for Cellular Immunotherapies, University of Pennsylvania Philadelphia, PA 19104, USA; GBM Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Philadelphia, PA 19104, USA; Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Ph
  • Nasrallah MP; GBM Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Philadelphia, PA 19104, USA; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Hu L; Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
  • Zhang L; Center for Cellular Immunotherapies, University of Pennsylvania Philadelphia, PA 19104, USA; GBM Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Philadelphia, PA 19104, USA; Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Ph
  • Zhang JV; Center for Cellular Immunotherapies, University of Pennsylvania Philadelphia, PA 19104, USA; GBM Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Philadelphia, PA 19104, USA; Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Ph
  • Logun MT; Center for Cellular Immunotherapies, University of Pennsylvania Philadelphia, PA 19104, USA; GBM Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Philadelphia, PA 19104, USA; Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Ph
  • Kainth D; Center for Cellular Immunotherapies, University of Pennsylvania Philadelphia, PA 19104, USA; GBM Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Philadelphia, PA 19104, USA; Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Ph
  • Haddad L; Center for Cellular Immunotherapies, University of Pennsylvania Philadelphia, PA 19104, USA; GBM Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Philadelphia, PA 19104, USA; Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Ph
  • Zhao Y; Department of Operating Room, First Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
  • Wu T; Department of Ultrasound, Second Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
  • Johns EX; Center for Cellular Immunotherapies, University of Pennsylvania Philadelphia, PA 19104, USA; GBM Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Philadelphia, PA 19104, USA; Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Ph
  • Long Y; Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
  • Liang H; Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
  • Qi J; Department of Pathology, First Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
  • Zhang X; Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
  • Binder ZA; Center for Cellular Immunotherapies, University of Pennsylvania Philadelphia, PA 19104, USA; GBM Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Philadelphia, PA 19104, USA; Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Ph
  • Lin Z; Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, 150001, China. Electronic address: linzhiguo@hotmail.com.
  • O'Rourke DM; Center for Cellular Immunotherapies, University of Pennsylvania Philadelphia, PA 19104, USA; GBM Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania Philadelphia, PA 19104, USA; Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Ph
Mol Ther ; 30(7): 2537-2553, 2022 07 06.
Article in En | MEDLINE | ID: mdl-35570396
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Glioblastoma / Interleukin-13 Receptor alpha2 Subunit Type of study: Prognostic_studies Limits: Animals Language: En Journal: Mol Ther Journal subject: BIOLOGIA MOLECULAR / TERAPEUTICA Year: 2022 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Glioblastoma / Interleukin-13 Receptor alpha2 Subunit Type of study: Prognostic_studies Limits: Animals Language: En Journal: Mol Ther Journal subject: BIOLOGIA MOLECULAR / TERAPEUTICA Year: 2022 Type: Article